BloodNet gets its first LIS vendor


Monday, 30 November, 2015

The National Blood Authority (NBA) has announced that Cirdan will be the first laboratory information system (LIS) vendor to fully interface with BloodNet, Australia’s national blood inventory management and supply chain system.

BloodNet automates the real-time exchange of hospital inventory levels of critical blood stocks and the status of each unit, providing laboratories with advantages including “a significant reduction in data entry time, increased data quality and additional real-time data streams”, according to NBA CIO Peter O’Halloran.

“This time-saving and enhanced data set enables these laboratories to more quickly service patient needs and to further improve their management of blood,” he continued.

The system will thus be an ideal tool for Cirdan’s Ultra laboratory information system, which is used to manage 24% of Australia’s blood supply. O’Halloran said the NBA is “excited to be working over the coming months with Cirdan and the pathology services that use Ultra to implement the interface at each of their facilities”.

“Our engagement with Cirdan to develop the interface has been invigorating — they have clearly seen the need, have dedicated resources to the project and, in a short period of time, delivered an outstanding product,” he said.

“With experience of working with government bodies in many jurisdictions, it has been both refreshing and a pleasure to work with the NBA,” added Cirdan CEO Hugh Cormican. “Their vision and strategy for the future are inspiring and exciting, and we are very happy to be a part of this. The BloodNet interface is now available as standard in our current release Ultra v4.5, and we will maintain it for all future versions.”

BloodNet won the Government and Victorian Government Inspiration awards in the national iAwards earlier this year.

Related News

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd